Tumor Neoantigenicity Assessment with CSiN Score Incorporates Clonality and Immunogenicity to Predict Immunotherapy Outcomes
Tianshi Lu, Shidan Wang, Lin Xu, Qinbo Zhou, Nirmish Singla, Jianjun Gao, Subrata Manna, Laurentiu M. Pop, Zhiqun Xie, Mingyi Chen, Jason J. Luke, James Brugarolas, Raquibul Hannan, Tao Wang
The paper introduces the CSiN score to predict immunotherapy outcomes by assessing tumor neoantigen quality through clonality and immunogenicity, showing improved performance over existing methods.
Science Immunology · Feb 14, 2020Peer-reviewedBioinformatics